Aim To assess morphological characteristics of carotid blood vessels in uremic patients before to the initiation of the dialysis treatment, and corelate data with various dialysis therapy modules. Methods The study included 30 patients with end-stage renal disease (ERDS) prior to commencing dialysis, 30 patients treated with haemodialysis and 30 patients treated with continuous ambulatory peritoneal dialysis. The control group consisted of 15 subjects with normal kidney function (eGFR>60ml/min). Carotid intima-media thickness (CIMT), as well as lipid status values (cholesterol, triglycerides, low-density lipoprotein (LDL), high-density lipoprotein (HDL), apolipoprotein A, apolipoprotein B) were evaluated. Results The significant difference in CIMT was detected between the control and haemodialysis groups (p<0.001), and between the control and the peritoneal dialysis group (p=0.004). In patients in the predialysis group, CIMT was influenced by cholesterol (p=0.013), HDL (p=0.044), LDL (p=0.001) and ApoB (p=0.042) values. A significant difference in CIMT was proved between the haemodialysis and predialysis group of patients (p<0.001). The only variable from the patient's lipometabolic profile significantly associated with the change in IMT in uremic patients was HDL. A significant difference was found in the average value for systolic blood pressure (p<0.001) and diastolic blood pressure (p=0.018) in patients before starting the dialysis treatment compared to patients treated with other dialysis methods. Conclusion Patients on haemodialysis treatment had a significantly greater CIMT, which is in relation with a higher cardiovascular risk.
Major RW, Cheng MRI, Grant RA, Shantikumar S, Xu G, Oozeerally I, et al. Cardiovascular disease risk factors in chronic kidney disease: a systematic review and meta-analysis. PLoS One 2018;13:e0192895.
2
Zvizdić F, Begić E, Dilić M, Sokolović Š, Lepara O. Effect of atorvastatin on systolic and diastolic function in patients with heart failure with reduced ejection fraction (HFrEF. Med Glas (Zenica 2021;18:357–61.
3
Kanbay M, Bavbek N, Delibasi T, Koca C, Kaya A, Altay M, et al. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease. Ren Fail 2007;29:309–13.
4
Holzer M, Schilcher G, Curcic S. Dialysis Modalities and HDL Composition and Function. J Am Soc Nephro 2015;26:2267–76.
5
Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, et al. Lipid management in patients with chronic kidney disease. Nat Rev Nephrol 2018;14:727–49.
6
Małyszko J, Łebkowska U, Małyszko JS, Myśliwiec M. Structural changes in carotid arteries and impairment of fibrinolysis in hemodialyzed and peritoneally dialyzed patients. Med Sci Monit 2009;15:CR644-9.
7
Ekart R, Hojs R, Hojs-Fabjan T, Balon BP. Predictive value of carotid intima media thickness in hemodialysis patients. Artif Organs 2005;29:615–9.
8
Nishizawa Y, Shoji T, Maekawa K, Nagasue K, Okuno S, Kim M, et al. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2003;41:S76:9.
9
Shoji T, Emoto M, Tabata T, Kimoto E, Shinohara K, Maekawa K, et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int 2002;61:2187–92.
10
Mutluay R, Degertekin CK, Poyraz F, Yılmaz MI, Yücel C, Turfan M, et al. Dialysis type may predict carotid intima media thickness and plaque presence in end-stage renal disease patients. Adv Ther 2012;29:370–82.
11
Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004;24:469–73.
12
Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 2001;12;(245864).
13
Emma P, Mary RE, Elena K, Alun HD, Edwina AB. Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD. Am J Kidney Dis 2005;46:856–62.
14
Hinderliter A, Padilla RL. Association of carotid intima-media thickness with cardiovascular risk factors and patient outcomes in advanced chronic kidney disease: the RRI-CKD study. Clin Nephrol 2015;84:10–20.
15
Vaidya A, N.R. Chronic Renal Failure 2022.
16
Junyent M, Martínez M, Borràs M, Coll B, Valdivielso JM, Vidal T, et al. Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study. BMC Nephrol 2010;11;(14).
17
Sheppard JP, Lacy P, Lewis PS, Martin U. Blood Pressure Measurement Working Party of the British and Irish Hypertension Society. Measurement of blood pressure in the leg-a statement on behalf of the British and Irish Hypertension Society. J Hum Hypertens 2020;34:418–9.
18
Funamizu T, Iwata H, Chikata Y, Doi S, Endo H, Wada H, et al. A prognostic merit of statins in patients with chronic hemodialysis after percutaneous coronary intervention-a 10-year follow-up study. J Clin Med 2022;11;(390).
19
Miseljic S, Aziri B, Begic E, Rebic D, Džubur A, Mišeljic N, et al. Hemodialysis parameters and pulse wave velocity. Int J App Basic Med Res 2022:1–7.
20
Lokesh S, Kadavanu TM, Green D, TK H, R R, AK T, et al. A Comparative study of lipid profile and cardiovascular risk biomarkers among chronic haemodialysis patients and healthy individuals. J Clin Diagn Res 2016;10:OC15-9.
21
London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731–40.
22
Sutliff RL, Walp ER, El-Ali AM, Elkhatib S, Lomashvili KA, O’Neill WC. Effect of medial calcification on vascular function in uremia. Am J Physiol Renal Physiol 2011;301:F78-83.
23
Zwakenberg de J, PA H, EJ W, J S, W de B, GJ C, et al. Intimal and medial calcification in relation to cardiovascular risk factors. PLoS One 2020;15:e0235228.
24
Obradovic S, Begic E, Jankovic S, Romanovic R, Djenic N, Dzudovic B, et al. Association of PC and AT levels in the early phase of STEMI treated with pPCI with LV systolic function and 6-month MACE. Acta Clin Belg 2020:1–7.
25
Begic E, Obradovic S, Jankovic S, Romanovic R, Djenic N, Dzudovic B, et al. Increased C-reactive protein is associated with major adverse cardiovascular events after STEMI. Erciyes Med J 2020;42:276–80.
26
Neto RM, Ramos JGL, Medjedovic E, Begic E. Increased of the carotid intima media thickness in preeclampsia. J Perinat Med 2020;48:787–91.
27
Thiery A, Séverac F, Hannedouche T, Couchoud C, Do VH, Tiple A, et al. Survival advantage of planned haemodialysis over peritoneal dialysis: a cohort study. Nephrol Dial Transplant 2018;33:1411–9.
28
Šečić D, Turohan A, Begić E, Rebić D, Pepić E, Begić Z, et al. Serum creatinine versus corrected Cockcroft-Gault equation according to Poggio reference values in patients with arterial hypertension. Int J Appl Basic Med Res 2022;12:9–13.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
